ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group.

58,050 patients entering 1086 hospitals up to 24 h (median 8 h) after the onset of suspected acute myocardial infarction (MI) with no clear contraindications to the study treatments (in particular, no cardiogenic shock or persistent severe hypotension) were randomised in a "2 x 2 x 2 factorial&...

সম্পূর্ণ বিবরণ

গ্রন্থ-পঞ্জীর বিবরন
প্রধান লেখক:	Collins, R, Peto, R, Flather, M, Parish, S, Sleight, P, Conway, M, Pipilis, A, Baigent, C, Barnett, D, Boissel, J, Budaj, A, Cairns, J, Ceremuzynski, L, Cohen, A, Debacker, G, Diaz, R, Dienstl, F, Dove, P, Franzosi, M, Genoni, M, Halon, D, Heikkila, J, Hennekens, C, Horgan, J, Hunt, D
বিন্যাস:	Journal article
ভাষা:	English
প্রকাশিত:	1995

ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group.

অনুরূপ উপাদানগুলি